BHARAT IMMUNOLOGICALS Selected Fundamentals

BHARAT IMMUNOLOGICALS fundamental analysis lookup allows you to check this and other indicators for BHARAT IMMUNOLOGICALS BIOLOG or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

BHARAT IMMUNOLOGICALS Cash per Share Analysis

Cash per Share is a ratio of current cash on hands or in the banks of the company to total number of shares outstanding. It is used to determine firm's liquidity and is a good indicator of overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Cash per Share 
 = 
Total Cash 
Average Shares 
More About Cash per Share | All Equity Analysis
BHARAT IMMUNOLOGICALS Cash per Share  =
4.25 
BHARAT IMMUNOLOGICALS ValuationFundamentalsBuy or Sell

About Cash per Share

Companies with high Cash per Share ratio will be considered as attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentalsCompare to competition
In accordance with recently published financial statements BHARAT IMMUNOLOGICALS BIOLOG has Cash per Share of 4.25 times. This is 2.3% lower than that of the Healthcare sector, and about the same as Biotechnology (which currently averages 4.33) industry, The Cash per Share for all stocks is 15.17% higher than the company.

BHARAT IMMUNOLOGICALS Fundamental Drivers Relationships

BHARAT IMMUNOLOGICALS BIOLOG is rated second in cash and equivalents category among related companies. It is rated second in shares outstanding category among related companies creating about  0.24  of Shares Outstanding per Cash and Equivalents. The ratio of Cash and Equivalents to Shares Outstanding for BHARAT IMMUNOLOGICALS BIOLOG is roughly  4.23 

Did you try this?

Run Fundamentals Matrix Now

   

Fundamentals Matrix

View fundamentals matrix and analyze how accounts are interrelated and interconnected with each other
All  Next Launch Module

BHARAT IMMUNOLOGICALS current financial ratios



 
Search macroaxis.com